(Q37881037)

English

Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation

scientific article published on December 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Atrial Fibrillation

0 references

author name string

Anique Ducharme

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Ernesto L Schiffrin

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

publication date

1 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

The Canadian Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

26 Suppl E

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

21E-23E

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Epidemiologic features of chronic atrial fibrillation: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial electrophysiologic remodeling: another vicious circle?

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Irbesartan in patients with heart failure and preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of lisinopril in patients with heart failure and chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Losartan and prevention of atrial fibrillation recurrence in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan for prevention of recurrent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Candesartan in the prevention of relapsing atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0828-282X%2810%2971170-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0828-282X(10)71170-3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37881037&oldid=2237172821"